Patents by Inventor Adria BYKOWSKI JONAS

Adria BYKOWSKI JONAS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BETA-GLUCAN IN COMBINATION WITH ANTI-CANCER AGENTS AFFECTING THE TUMOR MICROENVIRONMENT
    Publication number: 20220047620
    Abstract: The present invention relates to the combination of soluble ?-glucan and anti-cancer agents that affect the tumor microenvironment. Soluble ?-glucan promotes an immunostimulatory environment, which allows enhanced effectiveness of anti-cancer agents.
    Type: Application
    Filed: March 29, 2021
    Publication date: February 17, 2022
    Inventors: Nandita Bose, Keith Gorden, Anissa SH. Chan, Steven Leonardo, Jeremy Graff, Xiaohong Qiu, Takashi Kangas, Kathryn A. Fraser, Adria Bykowski Jonas, Nadine Ottoson, Ross Fulton
  • BETA-GLUCAN METHODS AND COMPOSITIONS THAT AFFECT THE TUMOR MICROENVIRONMENT
    Publication number: 20210283169
    Abstract: This disclosure relates to the combination of soluble ?-glucan and immune suppression-relieving agents that affect the tumor microenvironment. Soluble ?-glucan promotes an immunostimulatory environment, which allows enhanced effectiveness of anti-angiogenics, checkpoint inhibitors including non-tumor targeting antibodies.
    Type: Application
    Filed: March 29, 2021
    Publication date: September 16, 2021
    Inventors: Nandita Bose, Keith Gorden, Anissa SH. Chan, Steven Leonardo, Jeremy Graff, Xiaohong Qiu, Takashi Kangas, Kathryn A. Fraser, Adria Bykowski Jonas, Nadine Ottoson, Ross Fulton
  • BETA-GLUCAN IN COMBINATION WITH ANTI-CANCER AGENTS AFFECTING THE TUMOR MICROENVIRONMENT
    Publication number: 20190060351
    Abstract: The present invention relates to the combination of soluble ?-glucan and anti-cancer agents that affect the tumor microenvironment. Soluble ?-glucan promotes an immunostimulatory environment, which allows enhanced effectiveness of anti-cancer agents.
    Type: Application
    Filed: October 29, 2018
    Publication date: February 28, 2019
    Inventors: Nandita BOSE, Keith GORDEN, Anissa SH. CHAN, Steven LEONARDO, Jeremy GRAFF, Xiaohong QIU, Takashi KANGAS, Kathryn A. FRASER, Adria BYKOWSKI JONAS, Nadine OTTOSON, Ross FULTON
  • BETA-GLUCAN METHODS AND COMPOSITIONS THAT AFFECT THE TUMOR MICROENVIRONMENT
    Publication number: 20190060350
    Abstract: This disclosure relates to the combination of soluble ?-glucan and immune suppression-relieving agents that affect the tumor microenvironment. Soluble ?-glucan promotes an immunostimulatory environment, which allows enhanced effectiveness of anti-angiogenics, checkpoint inhibitors including non-tumor targeting antibodies.
    Type: Application
    Filed: October 29, 2018
    Publication date: February 28, 2019
    Inventors: Nandita BOSE, Keith GORDEN, Anissa SH. CHAN, Steven LEONARDO, Jeremy GRAFF, Xiaohong QIU, Takashi KANGAS, Kathryn A. FRASER, Adria BYKOWSKI JONAS, Nadine OTTOSON, Ross FULTON
  • ?-glucan methods and compositions that affect the tumor microenvironment
    Patent number: 10111900
    Abstract: This disclosure relates to the combination of soluble ?-glucan and immune suppression-relieving agents that affect the tumor microenvironment. Soluble ?-glucan promotes an immunostimulatory environment, which allows enhanced effectiveness of anti-angiogenics, checkpoint inhibitors including non-tumor targeting antibodies.
    Type: Grant
    Filed: December 21, 2016
    Date of Patent: October 30, 2018
    Assignee: BIOTHERA, INC.
    Inventors: Nandita Bose, Keith Gorden, Anissa Sh. Chan, Steven Leonardo, Jeremy Graff, Xiaohong Qiu, Takashi Kangas, Kathryn A. Fraser, Adria Bykowski Jonas, Nadine Ottoson, Ross Fulton
  • Beta-glucan in combination with anti-cancer agents affecting the tumor microenvironment
    Patent number: 10111901
    Abstract: The present invention relates to the combination of soluble ?-glucan and anti-cancer agents that affect the tumor microenvironment. Soluble ?-glucan promotes an immunostimulatory environment, which allows enhanced effectiveness of anti-cancer agents.
    Type: Grant
    Filed: December 21, 2016
    Date of Patent: October 30, 2018
    Assignee: BIOTHERA, INC.
    Inventors: Nandita Bose, Keith Gorden, Anissa S H. Chan, Steven Leonardo, Jeremy Graff, Xiaohong Qiu, Takashi Kangas, Kathryn A. Fraser, Adria Bykowski Jonas, Nadine Ottoson, Ross Fulton
  • BETA-GLUCAN METHODS AND COMPOSITIONS THAT AFFECT THE TUMOR MICROENVIRONMENT
    Publication number: 20170100424
    Abstract: This disclosure relates to the combination of soluble ?-glucan and immune suppression-relieving agents that affect the tumor microenvironment. Soluble ?-glucan promotes an immunostimulatory environment, which allows enhanced effectiveness of anti-angiogenics, checkpoint inhibitors including non-tumor targeting antibodies.
    Type: Application
    Filed: December 21, 2016
    Publication date: April 13, 2017
    Inventors: Nandita BOSE, Keith GORDEN, Anissa SH. CHAN, Steven LEONARDO, Jeremy GRAFF, Xiaohong QIU, Takashi KANGAS, Kathryn A. FRASER, Adria BYKOWSKI JONAS, Nadine OTTOSON
  • BETA-GLUCAN IN COMBINATION WITH ANTI-CANCER AGENTS AFFECTING THE TUMOR MICROENVIRONMENT
    Publication number: 20170100425
    Abstract: The present invention relates to the combination of soluble ?-glucan and anti-cancer agents that affect the tumor microenvironment. Soluble ?-glucan promotes an immunostimulatory environment, which allows enhanced effectiveness of anti-cancer agents.
    Type: Application
    Filed: December 21, 2016
    Publication date: April 13, 2017
    Inventors: Nandita BOSE, Keith GORDEN, Anissa SH. CHAN, Steven LEONARDO, Jeremy GRAFF, Xiaohong QIU, Takashi KANGAS, Kathryn A. FRASER, Adria BYKOWSKI JONAS, Nadine OTTOSON